Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Friday, August 22 2014 5:38pm ET - U.S. Markets Closed.
Industry Center - Drug Manufacturers - Major
Industry Center > Drug Manufacturers - Major > Merck & Co., Inc. Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
· REIT - Retail
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
Merck & Co., Inc. Company Profile
Merck makes medicines for a number of maladies, from stuffy noses and asthma to hypertension and arthritis. The pharmaceutical giant's top prescription drugs include diabetes drug Januvia, asthma medication Singulair, anti-inflammatory Remicade, cholesterol combatants Vytorin and Zetia, and hypertension fighters Cozaar and Hyzaar. In addition, Merck makes childhood and adult vaccines for such diseases as measles, mumps, pneumonia, and shingles, as well as veterinary pharmaceuticals through Merck Animal Health. The company's OTC drug and personal care offerings include Claritin allergy pills and Dr. Scholl's foot care products.
Headlines for Merck & Co., Inc.
Heart Doctor Pay Drops To $558K As Interventions Scrutinized
at Forbes.com - Fri 9:00 am ET
This stock may be hazardous to your financial health
- Tue Aug 19
Washington Post Off Base In Critiquing Pharma Efforts In Ebola
at Forbes.com - Mon Aug 18
Biotech Leader Gilead Sciences Scores Sovaldi Win
at Investor's Business Daily, Inc. - Fri Aug 15
More Headlines...
More on Merck & Co., Inc.
Quote Insider
Chart Financials
Profile Analyst Ratings
Research    
Msgs    
Contact Information
Address: 1 Merck Dr.
Whitehouse Station, NJ 08889-0100
Phone:908-423-1000
Fax:908-735-1253
Financial Highlights
Fiscal Year End:December
Revenue (2013):44033.00 M
Revenue Growth (1 yr):(-6.80%)
Employees (2013):76,000
Employee Growth (1 yr):(-8.40%)
Key People
Chairman, President, and CEO: Kenneth C. (Ken) Frazier
EVP and CFO: Robert M. Davis
EVP and CIO: Clark Golestani
Industry Information
Sector: Healthcare
Industry: Drug Manufacturers - Major
Top Competitors
GlaxoSmithKline plc (gsk)
Novartis AG (nvs)
Pfizer Inc. (pfe)
 


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?